CN Patent

CN109641890B — 异柠檬酸脱氢酶(idh)抑制剂

Assigned to Zhejiang Maitong Biomedical Co ltd · Expires 2022-04-26 · 4y expired

What this patent protects

本申请公开了抑制α‑KG转化为D‑2‑HG的化合物，其药学上可接受的盐、水合物、溶剂化物或立体异构体，以及包含所述化合物的药物组合物。所述化合物和所述药物组合物能够有效地治疗IDH相关的疾病，包括癌症。

USPTO Abstract

本申请公开了抑制α‑KG转化为D‑2‑HG的化合物，其药学上可接受的盐、水合物、溶剂化物或立体异构体，以及包含所述化合物的药物组合物。所述化合物和所述药物组合物能够有效地治疗IDH相关的疾病，包括癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN109641890B
Jurisdiction
CN
Classification
—
Expires
2022-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Maitong Biomedical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.